Loading...
NPI 1225457880 · Quincy, MA · Dermatology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Christina Correnti is a dermatology physician provider located in Quincy, Massachusetts. This profile covers 26 Medicare and 8 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Christina Correnti |
| Address | 104 Quarry St Ste 2 |
| City | Quincy |
| State | MA |
| ZIP | 02169 |
| Taxonomy | Dermatology Physician |
| NPI Enumerated | April 10, 2014 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $526.8K |
| Medicaid | $74.7K |
This provider’s revenue mix is Medicare‑heavy: lifetime Medicare revenue is $526.8K versus Medicaid revenue of $74.7K, so Medicare is the primary payer by a large margin and likely drives the practice’s case selection and investment decisions. The distribution suggests the provider operates mainly in the senior market for high‑value procedures while maintaining a smaller Medicaid panel for office visits and routine care.
Medicare revenue is highly concentrated in Mohs and related surgical codes: the precomputed top‑3 Medicare codes account for 61.3% of Medicare revenue, with 17311 contributing $181.8K (34.5%), 17313 $84.7K (16.1%), and 17312 $56.5K (10.7%). This concentration indicates the practice’s Medicare business is driven primarily by multi‑stage excisional (Mohs) procedures rather than purely office‑based management.
Within Medicare, the provider shows a mixed competitive standing on flagship Mohs codes: 17313 ranks at the 89th percentile nationally (rank #249 of 2300), indicating a comparatively strong volume for that specific Mohs code, while 17311 and 17312 sit at more typical volumes (66th and 58th percentiles respectively). These percentiles imply the provider is a meaningful regional source for Mohs 17313 procedures but otherwise a modest participant nationally for related Mohs codes.
Beyond Mohs, the Medicare code mix includes substantial reconstructive and complex closure work, signaling an integrated surgical practice: codes such as 13121 ($30.9K, 5.9%), 13132 ($27.6K, 5.2%), and 13101 ($26.8K, 5.1%) appear on the top list, and 13101 is identified as notably above typical national volume (95th percentile). The presence of 15260 and multiple flap/repair codes further supports that the provider performs post‑excisional reconstruction and grafting in addition to tumor removal.
Medicaid billing is concentrated in evaluation & management (E/M) visits rather than high‑complexity Mohs: the precomputed top‑3 Medicaid codes account for 73.0% of Medicaid revenue, led by 99214 ($30.8K, 41.3%), 99213 ($14.1K, 18.9%), and 99203 ($9.6K, 12.8%). This payer‑specific case mix implies that Medicaid patients primarily generate office visit revenue while surgical procedures are proportionally more represented in Medicare.
Competitive standing in Medicaid is generally middle‑of‑the‑road for E/M codes: 99214, 99213, and 99203 all rank near the state median (52nd–53rd percentiles), so the provider is a typical in‑state participant for office visits rather than a dominant Medicaid E/M provider. Procedure‑level Medicaid ranks (for example, 17110 at the 32nd percentile) likewise reflect presence but not leadership in lesion destruction services.
The provider has an established NPI tenure (enumerated on 2014-04-10, ~12 years ago), which combined with the procedural mix suggests an outpatient dermatologic practice that has scaled Mohs and reconstructive services over multiple years. That tenure supports continuity of referrals and the infrastructure needed for staged procedures and pathology support.
Both payer mixes show revenue concentration in a small set of codes (top‑3 Medicare = 61.3% and top‑3 Medicaid = 73.0%), which is a double‑edged signal: it reflects a clear specialty focus (Mohs and reconstructive surgery for Medicare; office E/M for Medicaid) that can be an advantage in network negotiations, but it also creates exposure to reimbursement or coding policy changes that affect those few high‑value codes. Analysts should monitor reimbursement trends for Mohs codes and high‑volume E/M levels when assessing financial risk and contracting strategy.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
26 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 17311 | Mohs surgery is a multi–staged procedure that is performed to excise a malignant lesion layer by layer, along with histo–pathological assessment. The assessment is performed to ensure that the… | 350 | $520 | $181.8K |
| 17313 | Mohs surgery is a multi–staged method of excising a malignant lesion layer by layer, along with histo–pathological assessment, to ensure negative malignancy of the margins. | 160 | $520 | $84.7K |
| 17312 | Mohs surgery is a multi–staged method of excising a malignant lesion layer by layer, along with histo–pathological assessment, to ensure negative malignancy of the margins. | 160 | $350 | $56.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 430 | $70 | $31.1K |
| 13121 | This is for a complex repair of a wound to the scalp, arms, and/or legs. This wound should be 2.6 to 7.5 cm in size. | 120 | $260 | $30.9K |
| 13132 | The provider repairs a wound measuring 2.6 cm to 7.5 cm in size of the cheeks, chin, mouth, neck, axillae, genitalia, hands, and/or feet, which may require scar revision, debridement extensive… | 130 | $210 | $27.6K |
| 13101 | This is for a complex repair of a wound to the trunk. This wound should be 2.6 to 7.5 cm in size. | 90 | $290 | $26.8K |
| 15260 | This code is for a free full–thickness skin graft of the nose, ears, eyelids, and/or lips that is 20 cm2 or less in size. | 20 | $840 | $16K |
| 17314 | Mohs surgery is a multi–staged method of excising a malignant lesion layer by layer, along with histo–pathological assessment, to ensure negative malignancy of the margins. | 40 | $330 | $12.6K |
| 14041 | The provider replaces the lesions in the forehead, cheeks, chin, mouth, neck, axillae or armpits, genitalia, hands, or feet with the healthy tissues from an adjacent site. This code represents a… | 10 | $720 | $10.1K |
Showing 1–10 of 26
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 26 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
26 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 17311 | 8 | 60 | 360 | $450 | $169.9K |
| 17312 | 8 | 60 | 180 | $320 | $70.8K |
| 88305 | 66 | 520 | 530 | $40 | $53.4K |
| 17313 | 1 | 60 | 90 | $440 | $45.1K |
| 15260 | 5 | 50 | 20 | $810 | $29.2K |
| 13132 | 4 | 60 | 70 | $220 | $21.7K |
| 14041 | 6 | 30 | 20 | $750 | $21.6K |
| 99214 | 2,153 | 15,410 | 110 | $80 | $15.6K |
| 14021 | 2 | 10 | 20 | $700 | $14.8K |
| 13121 | 1 | 70 | 40 | $240 | $14.1K |
Showing 1–10 of 26
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
8 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 220 | $140 | $30.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 280 | $50 | $14.1K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 110 | $80 | $9.6K |
| 17110 | The provider destroys benign lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of one to 14 lesions other than skin tags or… | 90 | $90 | $7.4K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 50 | $130 | $5.8K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 140 | $30 | $4.2K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 50 | $30 | $1.5K |
| 17000 | The provider destroys a premalignant lesion using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of the first or only lesion. | 30 | $40 | $1.2K |
How this provider's Medicaid billing volume and revenue compare to other Massachusetts providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Massachusetts median
8 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 587 | 950 | 90 | $100 | $212.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,440 | 5,040 | 200 | $70 | $209.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 2,487 | 5,300 | 230 | $60 | $164.5K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 223 | 350 | 380 | $30 | $118.2K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 525 | 870 | 90 | $100 | $82K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 474 | 990 | 100 | $80 | $75.6K |
| 17110 | The provider destroys benign lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of one to 14 lesions other than skin tags or… | 49 | 70 | 240 | $100 | $66.1K |
| 17000 | The provider destroys a premalignant lesion using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of the first or only lesion. | 24 | 30 | 110 | $60 | $14.6K |
Other providers in the same ZIP code as Christina Correnti, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.